<DOC>
	<DOCNO>NCT00189943</DOCNO>
	<brief_summary>The purpose study collect information safety , tolerability immunogenicity investigational smallpox vaccine different dos use different route administration vaccinia-naive vaccinate healthy volunteer</brief_summary>
	<brief_title>Study Safety , Tolerability Immunogenicity MVA Vaccine Administered Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Smallpox</mesh_term>
	<criteria>Healthy male subject , age 20 55 year Signed informed consent Prior vaccination smallpox ( study part I ) Abnormalities suspicious underlie disease , detect routine test prior study inclusion . Any immune modifying therapy within 4 week prior entry Participation investigate drug trial Known allergy component may part vaccine Allergic reaction severe adverse effect experience previous smallpox vaccination ( study Part II )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>